Evaluation of the role of 18F-di-idrossi-fenil-alanina 18F-DOPA in images diagnostic by Positron Emission Tomography PET in study of human neuroendocrin neoplasia. - ND
- Conditions
- euroendocrin neoplasie carcinoid, thyroid medullary carcinoma, neuroendocrin neoplasie, feocromocitoma, melanoma and neuroblastoma .MedDRA version: 6.1Level: HLTClassification code 10014714
- Registration Number
- EUCTR2005-006209-16-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Adult subjects age 18 years of both sex, carriers of neuroendocrin neoplasie. Patients in pediatric age affections from neuroblastoma
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- subject unsound of mind; - age 18 years; - women in pregnancy; - women in breast-feeding; - patients in emergency situation.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method